GR3036646T3 - Formulations containing oxaliplatin - Google Patents

Formulations containing oxaliplatin

Info

Publication number
GR3036646T3
GR3036646T3 GR20010401504T GR20010401504T GR3036646T3 GR 3036646 T3 GR3036646 T3 GR 3036646T3 GR 20010401504 T GR20010401504 T GR 20010401504T GR 20010401504 T GR20010401504 T GR 20010401504T GR 3036646 T3 GR3036646 T3 GR 3036646T3
Authority
GR
Greece
Prior art keywords
formulations containing
containing oxaliplatin
oxaliplatin
formulations
Prior art date
Application number
GR20010401504T
Other languages
English (en)
Inventor
Nicholas H Anderson
Ross Blundell
Stephen Brown
David A England
Martin R Gray
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10827600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3036646(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of GR3036646T3 publication Critical patent/GR3036646T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
GR20010401504T 1998-02-25 2001-09-18 Formulations containing oxaliplatin GR3036646T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9804013.2A GB9804013D0 (en) 1998-02-25 1998-02-25 Formulations

Publications (1)

Publication Number Publication Date
GR3036646T3 true GR3036646T3 (en) 2001-12-31

Family

ID=10827600

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401504T GR3036646T3 (en) 1998-02-25 2001-09-18 Formulations containing oxaliplatin

Country Status (27)

Country Link
US (1) US6306902B1 (el)
EP (1) EP0943331B1 (el)
JP (1) JP4430229B2 (el)
KR (1) KR20010041182A (el)
CN (1) CN1152718C (el)
AR (1) AR015524A1 (el)
AT (1) ATE202472T1 (el)
AU (1) AU757101B2 (el)
BR (1) BR9908273A (el)
CA (1) CA2261500C (el)
CZ (1) CZ302196B6 (el)
DE (1) DE69900162T2 (el)
DK (1) DK0943331T3 (el)
ES (1) ES2161085T3 (el)
GB (1) GB9804013D0 (el)
GR (1) GR3036646T3 (el)
GT (1) GT199900019A (el)
HU (1) HU224611B1 (el)
IL (1) IL137772A (el)
MX (1) MXPA00008195A (el)
NO (1) NO329900B1 (el)
PL (1) PL197948B1 (el)
PT (1) PT943331E (el)
RU (1) RU2207857C2 (el)
UA (1) UA70316C2 (el)
WO (1) WO1999043355A2 (el)
ZA (1) ZA991489B (el)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804013D0 (en) 1998-02-25 1998-04-22 Sanofi Sa Formulations
EP1121117B1 (fr) * 1998-10-14 2002-06-05 Debiopharm S.A. Conditionnement d'une preparation d'oxaliplatine
ES2206288T3 (es) * 1999-08-30 2004-05-16 Debiopharm S.A. Preparacion farmaceutica estable de oxiliplatino para su administracion por via parenteral.
US7070796B1 (en) 1999-08-30 2006-07-04 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation for parenteral administration
EP1341555A2 (fr) * 2000-12-12 2003-09-10 Debiopharm S.A. Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation
DE60220766T2 (de) 2001-03-02 2008-03-06 Debiopharm S.A. Verwendung eines eine oxaliplatinlösung beinhaltenden fläschchens
US20040186172A1 (en) 2001-07-02 2004-09-23 Houssam Ibrahim Oxaliplatin active substance with a very low content of oxalic acid
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
CA2388352A1 (en) * 2002-05-31 2003-11-30 Voiceage Corporation A method and device for frequency-selective pitch enhancement of synthesized speed
DE10314377A1 (de) * 2003-03-28 2004-10-07 Stada Arzneimittel Ag Gebrauchsfertige Oxaliplatin-Lösungen
US20050020556A1 (en) * 2003-05-30 2005-01-27 Kosan Biosciences, Inc. Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes
GB2441445B (en) * 2003-08-28 2008-04-23 Mayne Pharma Ltd Acid containing oxaliplatin formulation
CN101022790A (zh) * 2003-08-28 2007-08-22 梅恩医药有限公司 含有酸的奥沙利铂制剂
JP2007504177A (ja) * 2003-09-02 2007-03-01 プリヴァ−ラケマ，エー．エス． 医薬組成物、その製造方法及び治療上の使用
CZ300795B6 (cs) * 2003-09-02 2009-08-12 Pliva-Lachema A. S. Farmaceutická kompozice a zpusob její výroby
EP1704156A1 (en) 2003-11-25 2006-09-27 Platco Technologies (Proprietary) Limited Platinum(ii) complexes, preparation and use
AU2004297126B2 (en) * 2003-12-10 2010-11-25 Toudai Tlo, Ltd. Coordination complex of diaminocyclohexaneplatinum(II) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same
CN100471493C (zh) * 2003-12-17 2009-03-25 梅比欧法姆股份有限公司 含有奥沙利铂的脂质体制剂
WO2005102312A1 (en) * 2004-04-27 2005-11-03 Mayne Pharma Limited Concentrated oxaliplatin solutions
NZ553044A (en) 2004-09-01 2010-09-30 Placto Technologies Proprietar Preparations of platinum(II) complexes
US20060063833A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Ready-to-use oxaliplatin solutions
US20060063720A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Oxaliplatin solution concentrate
DE102004052877B4 (de) * 2004-11-02 2008-06-19 Ebewe Pharma Ges.M.B.H. Nfg.Kg Stabile wässrige Formulierungen eines Platin-Derivats
DE102004063764A1 (de) * 2004-12-29 2006-07-13 Hexal Ag Kunststoff-Flasche für Oxaliplatin
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
AU2005329764B2 (en) * 2005-03-28 2010-08-12 Dabur Pharma Ltd. Stable pharmaceutical compositions of platinum (II) antitumour agents
EP1874290A1 (en) * 2005-04-09 2008-01-09 Vuab Pharma A. S. A process for the preparation of an oxaliplatin preparation
RU2292210C1 (ru) * 2005-05-03 2007-01-27 Институт химии и химической технологии СО РАН (ИХХТ СО РАН) Способ получения стерилизованной микрокристаллической цис-дихлородиамминплатины (ii)
DE102005038347A1 (de) * 2005-08-11 2007-02-15 Hexal Ag Herstellung einer Oxaliplatin-Lösung und Behälter sowie Behälter-Set mit der Lösung
WO2007029268A2 (en) * 2005-09-05 2007-03-15 Dabur Pharma Limited Stable oxaliplatin formulation
RU2008135369A (ru) 2006-01-30 2010-03-10 Платко Текнолоджис (Проприэтэри) Лимитед (Za) Получение комплексов платины(ii)
KR100913063B1 (ko) 2006-09-13 2009-08-21 주식회사유한양행 옥살리플라틴-함유 주사용 용액
JP2010516717A (ja) * 2007-01-22 2010-05-20 プリヴァ−ラケマ，エー．エス． アルコール性糖ベースのバッファーを有するオキサリプラチン薬学的組成物
RU2340347C2 (ru) * 2007-01-24 2008-12-10 Институт химии и химической технологии СО РАН (ИХХТ СО РАН) Способ получения стерилизованной микрокристаллической соли цис-дихлороамминизопропиламинплатины (ii)
EP2152239A1 (en) * 2007-11-12 2010-02-17 Intas Pharmaceuticals Limited Stable oxaliplatin composition for parenteral administration
US20090130017A1 (en) * 2007-11-19 2009-05-21 Searete Llc Targeted short-lived drug delivery
WO2010056847A2 (en) * 2008-11-13 2010-05-20 Taigen Biotechnology Co., Ltd. Lyophilization formulation
CN101461801B (zh) * 2008-12-26 2013-05-15 辰欣药业股份有限公司 一种奥沙利铂药物组合物及其制备方法
EP2481396A4 (en) 2009-09-21 2014-03-05 Jw Pharmaceutical Corp OXALIPLATIN NANOPARTICLES AND MANUFACTURING METHOD THEREFOR
CN102274171A (zh) * 2011-08-04 2011-12-14 上海希迪制药有限公司 一种奥沙利铂注射剂
CN104523674B (zh) * 2014-12-11 2017-10-24 广州市上为医药科技有限公司 一种以奥沙利铂为主药成分的注射用组合物
KR101683635B1 (ko) * 2014-12-29 2016-12-09 가천대학교 산학협력단 락테이트 금속염을 포함하는 암 치료용 약학 조성물
CN104829653B (zh) * 2015-05-06 2016-03-23 山东罗欣药业集团股份有限公司 一种奥沙利铂水合物晶体及其冻干粉针剂
WO2019138379A1 (en) 2018-01-12 2019-07-18 Metimedi Pharmaceuticals Co., Ltd. Methods of treating chronic inflammatory diseases
CN117398349A (zh) * 2023-11-15 2024-01-16 苏州大学 一种奥沙利铂长循环脂质体及其制备方法与应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041077B2 (ja) * 1976-09-06 1985-09-13 喜徳 喜谷 １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
PT93772A (pt) 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer
WO1991009042A1 (fr) 1989-12-15 1991-06-27 Tsumura & Co. Nouveau complexe de platine et medicament antitumoral le contenant comme ingredient actif
JPH04185601A (ja) 1990-11-20 1992-07-02 Unitika Ltd 白金抗癌剤徐放性製剤
DK0612248T3 (da) 1991-11-15 2003-12-08 Smithkline Beecham Corp Præparat, der indeholder cisplatin og topotecan som antitumormiddel
JPH0776230B2 (ja) * 1992-01-13 1995-08-16 田中貴金属工業株式会社 白金化合物の製造方法
JPH05238936A (ja) 1992-02-27 1993-09-17 Dainippon Pharmaceut Co Ltd カルシトリオールの水性液剤
JPH06287021A (ja) * 1992-04-22 1994-10-11 Tanaka Kikinzoku Kogyo Kk 光学活性な白金錯化合物の光学的分割方法
JP2673331B2 (ja) * 1993-01-12 1997-11-05 田中貴金属工業 株式会社 光学的に高純度なシス―オキザラート（トランス―１―１，２―シクロヘキサンジアミン）白金（▲ｉｉ▼）
WO1994012193A1 (fr) * 1992-11-24 1994-06-09 Debiopharm S.A. Combinaison de cisplatine avec l'oxaliplatine
JP3025602B2 (ja) * 1993-05-21 2000-03-27 デビオファーム エス．アー． 光学的に高純度なシス−オキザラート（トランス−ｌ−１，２−シクロヘキサンジアミン）白金（ＩＩ）錯体の製造方法
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
IL114852A (en) 1994-08-08 2000-02-29 Debiopharm Sa Pharmaceutically stable preparation of oxaliplatinum
ES2206478T3 (es) * 1994-11-11 2004-05-16 Debiopharm S.A. Composiciones carcinostaticas que contienen cis-oxaliplatino y otra u otras sustancias carcinostaticas compatibles.
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
DK0801070T3 (da) 1996-04-10 2003-05-19 Debiopharm Sa Fremgangsmåde til fremstilling af platinforbindelse
JPH09294809A (ja) 1996-05-07 1997-11-18 Terumo Corp 薬液注入器具
GB9804013D0 (en) 1998-02-25 1998-04-22 Sanofi Sa Formulations

Also Published As

Publication number Publication date
JP2002504524A (ja) 2002-02-12
KR20010041182A (ko) 2001-05-15
CZ20003089A3 (cs) 2000-12-13
ATE202472T1 (de) 2001-07-15
MXPA00008195A (es) 2004-11-22
EP0943331B1 (en) 2001-06-27
HUP0103707A2 (hu) 2002-02-28
BR9908273A (pt) 2000-10-24
WO1999043355A2 (en) 1999-09-02
DE69900162T2 (de) 2002-04-18
PL343021A1 (en) 2001-07-30
GB9804013D0 (en) 1998-04-22
UA70316C2 (uk) 2004-10-15
NO20004240L (no) 2000-10-18
CN1291886A (zh) 2001-04-18
DK0943331T3 (da) 2001-10-15
HU224611B1 (hu) 2005-11-28
ES2161085T3 (es) 2001-11-16
GT199900019A (es) 2000-08-04
AU2632499A (en) 1999-09-15
WO1999043355A3 (en) 1999-11-04
AU757101B2 (en) 2003-01-30
IL137772A (en) 2006-04-10
HUP0103707A3 (en) 2004-07-28
CN1152718C (zh) 2004-06-09
CZ302196B6 (cs) 2010-12-15
US6306902B1 (en) 2001-10-23
PT943331E (pt) 2001-12-28
NO329900B1 (no) 2011-01-24
RU2207857C2 (ru) 2003-07-10
DE69900162D1 (de) 2001-08-02
EP0943331A3 (en) 1999-11-03
CA2261500A1 (en) 1999-08-25
EP0943331A2 (en) 1999-09-22
ZA991489B (en) 1999-09-30
CA2261500C (en) 2001-07-17
PL197948B1 (pl) 2008-05-30
NO20004240D0 (no) 2000-08-24
HK1036405A1 (en) 2002-01-04
AR015524A1 (es) 2001-05-02
JP4430229B2 (ja) 2010-03-10

Similar Documents

Publication Publication Date Title
GR3036646T3 (en) Formulations containing oxaliplatin
PL341372A1 (en) Cellecoxibe containing compositions
PL346541A1 (en) Glyphosate formulation
GB9811377D0 (en) Compositions
PL334568A1 (en) Paroxetin containing compositions
GB9805782D0 (en) Compositions
GB2339693B (en) Anti-mollusc compositions
GB9806312D0 (en) Novel formulations
GB9815002D0 (en) Formulations
GB9810180D0 (en) Novel formulation
GB9812818D0 (en) Dentfrice compositions
GB9806810D0 (en) Compositions
GB0016470D0 (en) Compositions
GB9815001D0 (en) Formulations
GB2336535B (en) Compositions
GB9809347D0 (en) Compositions
GB9810181D0 (en) Novel formulations
GB9816050D0 (en) Compositions
GB9819600D0 (en) Chemical compositions
GB9818278D0 (en) Compositions
GB9823645D0 (en) Formulation
SI1119359T1 (en) 2-methyl-thieno-benzodiazepine formulation
GB9818910D0 (en) Novel formulation
GB9818905D0 (en) Novel formulation
PL330972A1 (en) Tetrahydrolypstatin containing compositions